## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization
✍ Scribed by H. Herfarth; V. Gross; T. Andus; I. Caesar; H. Vogelsang; G. Adler; H. Malchow; A. Petri; M. Gierend; J. Schölmerich; The German/Austrian Budesonide Study Group
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 188 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Vitamin D is essential for osteopenia therapy in Crohn's disease (CD). The active form of vitamin-D (aVD) is the 1,25(OH)2D. There are no data available whether aVD or plain vitamin-D (pVD) has any advantage in managing osteoporosis in CD or has any effect on the activity of the disease
## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines
## Abstract To analyze the correlation between muscle sympathetic nerve activity (MSNA) and cardiac ^123^I‐metaiodobenzylguanidine (MIBG) uptake in patients with Parkinson's disease (PD), we measured both parameters in 14 PD patients who were 51 to 82 years of age (mean, 63.1 ± 8.7 years). The dura